Endoscopic Treatment of Helicobacter Pylori

Treatment of Helicobacter Pylori Infection: Endoscopic Medication VS Oral Medication

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022936

Enrollment

Unknown

Registered

2019-05-04

Start date

2019-05-03

Completion date

Unknown

Last updated

2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter Pylori Infection

Interventions

Group 1:Endoscopic Medication

Group 2:Oral Medication

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged =18 years any race or ethnicity; 2. Diagnosed with uncomplicated helicobacter pylori infection.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with none helicobacter pylori infection; 2. Complicated complications; 3. Life expectancy <2 years.

Design outcomes

Primary

Measure	Time frame
Rapid urease test;	—

Countries

China

Contacts

Public ContactZe-Hao Zhuang

First Affiliated Hospital of Fujian Medical University

zhuang203@yeah.net+86 13178032412

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026